Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03084471
Brief Title: An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies. (STRONG)

First Submitted : March 7, 2017
First Submitted that Met QC Criteria : March 20, 2017
First Posted : March 21, 2017

Results First Submitted : March 22, 2021
Results First Submitted that Met QC Criteria : May 20, 2021
Results First Posted : June 15, 2021

Last Update Submitted that Met QC Criteria : July 29, 2021
Last Update Posted : July 30, 2021